PHARMA, BIOTECH AND DEVICE COLLOQUIUM
Advanced Executive Education on the Interface of Regulation and
Business Strategy for Global Pharmaceutical, Biotechnology and Medical Device Enterprises
McCosh Hall
Princeton University
Princeton, New Jersey
June 6 - 9, 2004
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy
Woodrow Wilson School, Princeton University
"It is my pleasure to welcome attendees of the Pharma, Biotech and Device Colloquium to the campus of Princeton University. I hope that you will enjoy this unique experience to contemplate strategic issues in the future of the pharmaceutical, biotechnology and medical device sectors with the assistance of the first rate Colloquium faculty."
|
|
DIAMOND GRANTORS
|
|
|
SILVER GRANTORS
|
|
For future information about The Pharma, Biotech and Device Colloquium, please complete the form below.
|
|
|
SAVE THE DATE
|
Second Annual Pharma, Biotech and Device Colloquium
June 5-8, 2005
On the Campus of
Princeton University
Princeton, New Jersey
|
Keynote Speakers:
Patricia M. Danzon, Ph.D.
Celia Z. Moh Professor; Professor of Health Care Systems and Insurance and Risk Management, Wharton School, University of Pennsylvania, Author, Pharmaceutical Price Regulation: National Policies vs. Global Interests, Philadelphia, PA
Bob Franks
President, Healthcare Institute of New Jersey, Former New Jersey Congressman, Hillside, NJ
Robert S. Galvin, MD, MBA
Director, Global Healthcare, General Electric Company, Founding Member, The Leap Frog Group, Vice Chair, Washington Business Group on Health, Fairfield, CT
Fred Hassan, MBA
Chairman and Chief Executive Officer, Schering-Plough Corporation, Past Chairman, Pharmaceutical Research & Manufacturers of America (PhRMA), Kenilworth, NJ
Pat Kelly
President, US Pharmaceuticals, Vice President, Pfizer Inc., New York, NY
John C. Lechleiter, Ph.D.
Executive Vice President, Pharmaceutical Operations, Eli Lilly and Company, Indianapolis, IN
Peter Leddy
Vice President, Global HR Services, Dell Inc., Round Rock, TX
Robert McCallum, Esq.
Associate Attorney General Robert, United States Department of Justice, Washington, DC
Mark B. McClellan, MD, PhD
Administrator, Centers for Medicare & Medicaid Services, Washington, DC
Ian Morrison, Ph.D.
Senior Fellow, Institute for the Future, Founding Partner, Harris/Harvard Strategic Health Perspectives, Author, Healthcare in the New Millennium: Vision, Values and Leadership and The Second Curve: Managing the Velocity of Change, Menlo Park, CA
Uwe E. Reinhardt, Ph.D.
James Madison Professor of Political Economy, Woodrow Wilson School, Princeton University, Princeton, NJ
Humphrey Taylor
Chairman, Harris Poll and Harris Interactive, Chairman, National Council on Public Polls, Rochester, NY
P. Roy Vagelos, MD
Retired Chief Executive Officer and Chairman, Merck & Co., Bedminister, NJ
Colloquium Co Chairs:
Anthony Farino
Partner and Leader, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Chicago, IL
John K. Iglehart
Founding Editor, Health Affairs, National Correspondent, New England Journal of Medicine, Washington, DC
Ian Morrison, Ph.D.
Senior Fellow, Institute for the Future, Founding Partner, Harris/Harvard Strategic Health Perspectives, Author, Healthcare in the New Millennium: Vision, Values and Leadership and The Second Curve: Managing the Velocity of Change, Menlo Park, CA
Brenton L. Saunders, JD, MBA
Senior Vice President, Global Compliance and Business Practices, Schering-Plough Corporation, Past President, Health Care Compliance Association, Founder, International Association of Privacy Professionals, Kenilworth, NJ
Brian Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
Karen Williams
President, National Pharmaceutical Council, Reston, VA
Featured Faculty:
Eric Aaronson, Esq.
Corporate Counsel, Pfizer Learning Center, Pfizer Inc., Rye Brook, NY
Thomas W. Abrams, RPh, MBA
Director, Division of Drug Marketing, Advertising & Communications, Food and Drug Administration, Rockville, MD
Felix Arellano, MD
Managing Partner, Risk Management Resources, LLC, Former Chief Safety Officer, Pharmacia Corporation, Califon, NJ
G. Lawrence Atkins, Ph.D.
Senior Director, Public Policy and Reimbursement, Schering-Plough Corporation, Washington, DC
Grant P. Bagley, MD, JD
Partner, Arnold & Porter, Former Director, Coverage and Analysis Group, HCFA Office of Clinical Standards and Quality, Washington, DC
Valli Baldassano
Vice President, Global Compliance, Commercial Operations, Schering-Plough, Kenilworth, NJ
John Bentivoglio, Esq.
Partner, Arnold and Porter, Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, United States Department of Justice, Washington, DC
Rupert Bondy, Esq.
General Counsel, GlaxoSmithKline, Brentford, Middlesex, UK
Link Bonforte
Vice President, Government Affairs, Policy and Compliance, ConvaTec, Skillman, NJ
Charles Brock
Vice President and Chief Ethics and Compliance Officer, Abbott Laboratories, Abbott Park, IL
Gary Budney
Vice President and Compliance Officer, Global Supply Chain, Schering-Plough, Kenilworth, NJ
Kevin Buehler
Principal and Co chair, North American Risk Management Practice, McKinsey & Company, New York, NY
David J. Butler
Chief Operating Officer, Strategic Management Systems, Inc., Former Deputy Associate Administrator, Operations and Resource Management, Health Care Financing Administration, Alexandria, VA
Blair Childs
Executive Vice President, Strategic Planning and Implementation, Advanced Medical Technology Association (AdvaMed), Washington, DC
Michael Conway
Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Inc., Florham Park, NJ
Rose Crane
Executive Vice President, Pharmaceuticals Group Strategic Marketing, Johnson and Johnson Pharmaceutical Services LLC, Raritan NJ
David A. Crenshaw, Esq.
Legal Director, European Operations, Schering-Plough, Lucerne, Switzerland
Dan DiFilippo
Partner, PricewaterhouseCoopers, New York, NY
Margaret Foran (Invited)
Vice President, Corporate Governance and Corporate Secretary, Pfizer Inc.
Gary Giampetruzzi, Esq.
Senior Corporate Counsel, Pfizer Inc., New York, NY
Virginia Gibson, Esq.
Assistant U.S. Attorney, Chief, Civil Division, Eastern District of Pennsylvania, Philadelphia, PA<
Donald Green (Invited)
Board Member, Equitable Life Insurance
Eric B. Grossman, MD, FACP
Senior Director, Hypertension, Heart Failure and Diabetes, Pfizer Global Pharmaceuticals, Pfizer Inc., New York, NY
Judith Hazlewood, MBA
Director, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
Michael Kafrissen
Vice President for Clinical Affairs, Ortho-McNeil Pharmaceutical, a Johnson & Johnson Company, Raritan, NJ
Paul E. Kalb, MD, JD
Partner, Sidley Austin Brown & Wood, Washington, DC
Jonathon Kellerman
Senior Manager, PricewaterhouseCoopers, Philadelphia, PA
Richard F. Kingham, Esq.
Partner, Covington & Burling, Washington, DC
Jeffrey C. Lerner, Ph.D.
President and Chief Executive Officer, ECRI, Plymouth Meeting, PA
Liz Lewis, Esq.
Associate General Counsel, Millennium Pharmaceuticals, Inc., Cambridge, MA
Nancy S. Lurker
Chief Executive Officer and President, ImpactRx, Inc., Mt. Laurel, NJ
Joan Macaulay, Esq.
Associate, Sidley Austin Brown & Wood, Washington, DC
Mark Merritt
President & Chief Executive Officer, Pharmaceutical Care Management Association, Washington, DC
Joseph W. Metro, Esq.
Partner, Reed Smith, Washington, DC
Karen A. Morrissette, Esq.
Deputy Chief, Fraud Section, Criminal Division, United States Department of Justice, Washington, DC
David Moskowitz, MBA, R.Ph.
Senior Vice President and Healthcare Senior Analyst, Friedman, Billings, Ramsey Group, Inc., Arlington, VA
Francois Nader, MD, MBA
Senior Vice President, Medical Affairs North America, Aventis Pharmaceuticals, Bridgewater, NJ
Daniel A. Neff, Esq.
Managing Partner, Wachtell, Lipton, Rosen & Katz, New York, NY
Brien T. O'Connor, Esq.
Partner, Ropes & Gray LLP, Former Chief of Public Corruption and Special Prosecutions, United States Attorney's Office, Boston, MA
Claudio Pincus
President, Quantic, Livingston, NJ
Ethan M. Posner, Esq.
Partner and Chair, Health Care Practice Group, Covington & Burling, Former Deputy Associate Attorney General, Department of Justice
Washington, DC
Carol Pratt, JD, Ph.D.
Associate, Davis Wright Tremaine LLP, Portland, OR
Lori Queisser
Vice President and Chief Compliance Officer, Eli Lilly and Company
Indianapolis, IN
David Quigley
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Inc., New York, NY
Edwin D. Rauzi, Esq.
Partner, Davis Wright Tremaine LLP, Seattle, WA
Cavan Redmond
Executive Vice President and General Manager, BioPharma Business Unit, Wyeth Pharmaceuticals, Collegeville, PA
Michael Rennie
Director, McKinsey & Company, Inc., Sydney, Australia
Kimberly Richter (Invited)
Director, Office of Compliance, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD
Brian Riewerts
Senior Manager, Global Pharmaceutical Advisory Services Group, PricewaterhouseCoopers LLP, Baltimore, MD
Retta Riordan, Esq.
Riordan Consulting LLC, Former Assistant General Counsel, C.R. Bard, Inc., Former Associate General Counsel, HIMA (AdvaMed), Mountainside, NJ
Patrick D. Roche
Partner, PricewaterhouseCoopers, Florham Park, NJ
Thomas Sabatino, Esq.
General Counsel, Schering-Plough Corporation, Kenilworth, NJ
Brian S. Salsberg, JD
Associate Principal, Pharmaceutical and Medical Products Practice, McKinsey & Company, Florham Park, NJ
Sheva Sanders, Esq.
Principal Senior Counsel, Medtronic, Inc., Minneapolis, MN
Carl J. Seiden
Managing Director, JP Morgan Securities, New York, NY
Rob Seidman, PharmD, MPH
Chief Pharmacy Officer, WellPoint Health Networks, Thousand Oaks, CA
Ian Spatz
Vice President, Public Policy, Merck & Co., Inc., Washington, DC
John F. Sweeney, Esq.
Partner, Morgan and Finnegan, New York, NY
Gene Thirolf, Esq.
Director, Office of Consumer Litigation, U.S. Department of Justice, Washington, DC
L. Stephan Vincze, Esq.
Ethics & Compliance Officer, TAP Pharmaceuticals, Lake Forest, IL
William Vodra, Esq.
Partner, Arnold & Porter LLP, Former Associate Chief Counsel, Food and Drug Administration, Washington, DC
Mark Wanda, Esq.
Vice President, Legal Affairs, Sepracor Inc., Marlborough, MA
Bert Weinstein, Esq.
Vice President, Corporate Compliance, Purdue Pharma, Stamford, CT
Caroline H. West, Esq.
Vice President, Global Legal Compliance, Aventis, Bridgewater, NJ
Linda Willett, Esq.
Vice President and Deputy General Counsel, Bristol-Myers Squibb Company, New York, NY
|
|
